Cargando…

Prostatic artery embolization with polyethylene glycol microspheres: evaluation in a canine spontaneous benign prostatic hyperplasia model

BACKGROUND: Prostatic artery embolization (PAE) is a minimally invasive technique for the management of symptomatic benign prostatic hyperplasia (BPH) relieving the lower urinary tract symptoms in patients. Various embolic agents have been tested in animal models and subsequently used in human patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucas Cava, Vanesa, Sánchez Margallo, Francisco Miguel, Báez Díaz, Claudia, Dávila Gómez, Luis, Lima Rodríguez, Juan Rafael, Sun, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474033/ https://www.ncbi.nlm.nih.gov/pubmed/32886265 http://dx.doi.org/10.1186/s42155-020-00130-5

Ejemplares similares

Prostatic artery embolization: magnetic resonance image (MRI) findings in the early detection of prostate infarction in a canine spontaneous benign prostatic hyperplasia model
por: Lucas-Cava, Vanesa, et al.
Publicado: (2021)

Clinical predictive factors in prostatic artery embolization for symptomatic benign prostatic hyperplasia: a comprehensive review
por: Sun, Fei, et al.
Publicado: (2020)

Prostatic Artery Embolization (PAE) Using Polyethylene Glycol Microspheres: Safety and Efficacy in 81 Patients
por: Insausti, Iñigo, et al.
Publicado: (2022)

Correction to: Prostatic Artery Embolization (PAE) Using Polyethylene Glycol Microspheres: Safety and Efficacy in 81 Patients
por: Insausti, Iñigo, et al.
Publicado: (2023)

Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models
por: Sun, Fei, et al.
Publicado: (2017)

Prostatic artery occlusion: initial findings on pathophysiological response in a canine prostate model
por: Lucas-Cava, Vanesa, et al.
Publicado: (2022)

Comparison of Nonspherical Polyvinyl Alcohol Particles and Microspheres for Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia
por: Hwang, Jin Ho, et al.
Publicado: (2017)

Clinical Study on the Treatment of Benign Prostatic Hyperplasia by Embolization of Prostate Artery Based on Embosphere Microspheres and Gelatin Sponge Granules
por: Liu, Jinglei, et al.
Publicado: (2022)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Canine prostate models in preclinical studies of minimally invasive interventions: part I, canine prostate anatomy and prostate cancer models
por: Sun, Fei, et al.
Publicado: (2017)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
por: Radwan, Ahmed, et al.
Publicado: (2020)

3D printed model to assist endovascular prostate artery embolization for benign prostatic hyperplasia
por: Dalla, Shiv, et al.
Publicado: (2022)

Benign Prostatic Hyperplasia
Publicado: (2015)

Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
por: Zhang, Jin Long, et al.
Publicado: (2018)

Prostatic Artery Embolization for the Treatment of Benign Prostate Hyperplasia: Initial Experience From Bahrain
por: Hamed Ibrahim, Wael, et al.
Publicado: (2022)

Safety and efficacy of prostatic artery embolization for large benign prostatic hyperplasia in elderly patients
por: Xu, Chen, et al.
Publicado: (2021)

Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia
por: Pinheiro, Dora, et al.
Publicado: (2017)

Radiation dose of prostatic artery embolization for benign prostatic hyperplasia: A protocol for systematic review
por: Liu, Jinglei, et al.
Publicado: (2022)

Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis
por: Jiang, Yu-Li, et al.
Publicado: (2019)

Polyethylene glycol microspheres loaded with irinotecan for arterially directed embolic therapy of metastatic liver cancer
por: Fiorentini, Giammaria, et al.
Publicado: (2017)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Prostatic Artery Embolization as a Primary Treatment for Benign Prostatic Hyperplasia: Preliminary Results in Two Patients
por: Carnevale, Francisco Cesar, et al.
Publicado: (2009)

Clinical Outcomes of Prostatic Artery Embolization in Patients with Benign Prostatic Hyperplasia: A Prospective Clinical Study
por: Dogan, Kazım, et al.
Publicado: (2022)

Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization
por: Boschheidgen, Matthias, et al.
Publicado: (2023)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Radiological Findings of Prostatic Arterial Anatomy for Prostatic Arterial Embolization: Preliminary Study in 55 Chinese Patients with Benign Prostatic Hyperplasia
por: Zhang, Guodong, et al.
Publicado: (2015)

Modern imaging and image-guided treatments of the prostate gland: MR and ablation for cancer and prostatic artery embolization for benign prostatic hyperplasia
por: Dias, João Lopes, et al.
Publicado: (2019)

An Updated Meta-Analysis of the Efficacy and Safety of Prostatic Artery Embolization vs. Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia
por: Xu, Zhunan, et al.
Publicado: (2021)

Robotic-assisted simple prostatectomy after prostatic arterial embolization for large benign prostate hyperplasia: Initial experience
por: Kam, Sung-Chul, et al.
Publicado: (2022)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial
por: Napal Lecumberri, Saturnino, et al.
Publicado: (2018)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5sn0c8p3rjkrm0qsfmhn8qncn7